Thrombophlebitis: Difference between revisions

Jump to navigation Jump to search
Line 39: Line 39:
# Superficial thrombophlebitis of the [[abdominal wall]]
# Superficial thrombophlebitis of the [[abdominal wall]]


==[[Thrombophlebitis pathophysiology|Pathophysiology]]==
==Pathophysiology==
===Pathogenesis===
===Microscopic Pathology===
===Genetics===
===Associated Conditions===
Thrombophlebitis may be associated with the following conditions:
*[[Coagulation disorders|Coagulation abnormalities]]:<ref name="pmid26099257">{{cite journal |vauthors=Nasr H, Scriven JM |title=Superficial thrombophlebitis (superficial venous thrombosis) |journal=BMJ |volume=350 |issue= |pages=h2039 |year=2015 |pmid=26099257 |doi= |url=}}</ref><ref name="pmid10544900">{{cite journal |vauthors=Martinelli I, Cattaneo M, Taioli E, De Stefano V, Chiusolo P, Mannucci PM |title=Genetic risk factors for superficial vein thrombosis |journal=Thromb. Haemost. |volume=82 |issue=4 |pages=1215–7 |year=1999 |pmid=10544900 |doi= |url=}}</ref>
**[[Factor V Leiden mutation]]
**[[Prothrombin 20210a mutation|Prothrombin 20210 mutation]]
**[[Protein C deficiency]]
**[[Protein S deficiency]]
**[[Antithrombin III deficiency]]
*[[Thromboangiitis obliterans]] ([[Buerger's disease|Buerger's Disease]])<ref name="pmid10995867">{{cite journal |vauthors=Olin JW |title=Thromboangiitis obliterans (Buerger's disease) |journal=N. Engl. J. Med. |volume=343 |issue=12 |pages=864–9 |year=2000 |pmid=10995867 |doi=10.1056/NEJM200009213431207 |url=}}</ref>
*Underlying [[malignancy]], especially [[pancreatic adenocarcinoma|adenocarcinoma of the pancreas]] in the case of migratory thrombophlebitis<ref name="pmid20302205">{{cite journal |vauthors=Diaconu C, Mateescu D, Bălăceanu A, Marcu M, Jianu V, Stănică A |title=Pancreatic cancer presenting with paraneoplastic thrombophlebitis--case report |journal=J Med Life |volume=3 |issue=1 |pages=96–9 |year=2010 |pmid=20302205 |pmc=3019029 |doi= |url=}}</ref><ref name="pmid17496204">{{cite journal |vauthors=Varki A |title=Trousseau's syndrome: multiple definitions and multiple mechanisms |journal=Blood |volume=110 |issue=6 |pages=1723–9 |year=2007 |pmid=17496204 |pmc=1976377 |doi=10.1182/blood-2006-10-053736 |url=}}</ref>


==[[Thrombophlebitis causes|Causes]]==
==[[Thrombophlebitis causes|Causes]]==

Revision as of 21:26, 16 February 2017

Template:Thrombophlebitis For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: White Leg; phlebitis

Overview

Historical Perspective

  • In 1913, Burnham AC discussed thrombophlebitis in postoperative patients.[1]
  • Historically, the treatment of thrombophlebitis was purely surgical and consisted of removal of the thrombosed vein.[2]

Classification

Thrombophlebitis can be classified according to the cause into:[3]

Type of Thrombophlebitis Description
Sterile Most common type of thrombophlebitis
Traumatic Associated with the following conditions:
Infective Mostly due to prolonged IV cannulation
Migratory Recurrent thrombophlebitis at various sites. Associated with an underlying malignancy, most commonly adenocarcinoma of the pancreas

Thrombophlebitis may also be classified according to the site into:[4]

  1. Superficial thrombophlebitis of the lower limb: most common location and it involves the great and short saphenous veins
  2. Superficial thrombophlebitis of the arms
  3. Superficial thrombophlebitis of the breast: also known as Mondor's disease
  4. Superficial thrombophlebitis of the abdominal wall

Pathophysiology

Pathogenesis

Microscopic Pathology

Genetics

Associated Conditions

Thrombophlebitis may be associated with the following conditions:

Causes

Differentiating Thrombophlebitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Screening

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1


Template:WikiDoc Sources

  1. Burnham AC (1913). "II. Postoperative Thrombophlebitis". Ann. Surg. 57 (2): 151–62. PMC 1407408. PMID 17862964.
  2. Homans J (1928). "THROMBOPHLEBITIS OF THE LOWER EXTREMITIES". Ann. Surg. 87 (5): 641–51. PMC 1398549. PMID 17865873.
  3. 3.0 3.1 Nasr H, Scriven JM (2015). "Superficial thrombophlebitis (superficial venous thrombosis)". BMJ. 350: h2039. PMID 26099257.
  4. Scott G, Mahdi AJ, Alikhan R (2015). "Superficial vein thrombosis: a current approach to management". Br. J. Haematol. 168 (5): 639–45. doi:10.1111/bjh.13255. PMID 25521017.
  5. Martinelli I, Cattaneo M, Taioli E, De Stefano V, Chiusolo P, Mannucci PM (1999). "Genetic risk factors for superficial vein thrombosis". Thromb. Haemost. 82 (4): 1215–7. PMID 10544900.
  6. Olin JW (2000). "Thromboangiitis obliterans (Buerger's disease)". N. Engl. J. Med. 343 (12): 864–9. doi:10.1056/NEJM200009213431207. PMID 10995867.
  7. Diaconu C, Mateescu D, Bălăceanu A, Marcu M, Jianu V, Stănică A (2010). "Pancreatic cancer presenting with paraneoplastic thrombophlebitis--case report". J Med Life. 3 (1): 96–9. PMC 3019029. PMID 20302205.
  8. Varki A (2007). "Trousseau's syndrome: multiple definitions and multiple mechanisms". Blood. 110 (6): 1723–9. doi:10.1182/blood-2006-10-053736. PMC 1976377. PMID 17496204.